The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
30 March 2007
Employment effect (start)
1 April 2007
Foreseen end date
31 December 2007
Description
An expanding biotechnology and medical firm is set to create 300 new jobs.
Cambridge Antibody Technology is also moving into a new building at the city's Milton Science Park.
The firm is a bio-pharmaceutical specialist developing human antibody therapies to improve the quality of life of seriously ill patients.
The workforce is set to double in size by 2008 when the firm moves to the new building where it will carry out both research and manufacturing.
Sources
30 March 2007: BBC Website
Citation
Eurofound (2007), Cambridge Antibody Technology, Business expansion in United Kingdom, factsheet number 65187, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65187.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
